Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exocarpium Citri Grandis Phlegm Cough Solution for Adult Community-Acquired Pneumonia
ChiCTR2000039125Phase 4Not yet recruiting
- Sponsor
- Maoming People's Hospital
- Start
- Nov 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of exocarpium citri grandis in community-acquired pneumonia (CAP) (2 arms), sponsored by Maoming People's Hospital. Primary endpoints: BCSS score and VAS score for symptoms. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
exocarpium citri grandis
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR2000039125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039125.